Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Label-Free Morphometric Profiling of Renal Cell Carcinoma Using Digital Holographic Microscopy and Machine Learning.

Created on 12 Nov 2026

Authors

Eva R Schwark, Yazan A Almahdi, Ayah A Farhat, Besa Xhabija

Published in

Journal of biophotonics. Volume 19. Issue 11.

Abstract

Renal cell carcinoma (RCC) has a substantial mortality rate among urologic cancers today, and our current knowledge of the disease includes few distinct biomarkers, making early diagnosis particularly difficult. In this study, we utilized digital holographic microscopy (DHM) and quantitative phase imaging (QPI) to investigate trends in cell morphology and optical properties across 38 morphological and optical features in renal carcinoma cell lines UO-31 and SN12C, and renal epithelial cell line HK2. Dimensionality reduction techniques including PCA, t-SNE, and Spectral Embedding Analysis enabled clearer differentiation between cancerous and normal cells. Our findings reveal distinct morphological profiles, with UO-31 and SN12C characterized by greater elongation, coarser features, and lower optical thickness compared to HK2. A Random Forest ensemble classifier achieved a cross-validated accuracy of 99.50% and AUC values exceeding 0.999 for all three cell lines, with Irregularity and Texture Clustershade emerging as the most influential discriminatory features.

PMID:
43015250
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement